These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 7660858)

  • 1. The role of complement and antibodies in the impaired bactericidal activity of neonatal sera against gram-negative bacteria.
    Jankowski S
    Acta Microbiol Pol; 1995; 44(1):5-14. PubMed ID: 7660858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum bactericidal activity and phagocytosis in host defence against Haemophilus ducreyi.
    Lagergård T; Frisk A; Purvèn M; Nilsson LA
    Microb Pathog; 1995 Jan; 18(1):37-51. PubMed ID: 7783597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody-independent killing of gram-negative bacteria via the classical pathway.
    Clas F; Loos M
    Behring Inst Mitt; 1984 Nov; (76):59-74. PubMed ID: 6525148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies specific to surface antigens are not effective in complement-mediated killing of Haemophilus ducreyi.
    Frisk A; Ahmed HJ; Van Dyck E; Lagergård T
    Microb Pathog; 1998 Aug; 25(2):67-75. PubMed ID: 9712686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bactericidal and opsonic activities of normal sheep serum against gram-negative bacteria.
    Mittal KR; Ingram DG
    Am J Vet Res; 1975 Aug; 36(08):1189-93. PubMed ID: 1098532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mechanism for decreased resistance to infection by gram-negative organisms during acute alcoholic intoxication.
    Marr JJ; Spilberg I
    J Lab Clin Med; 1975 Aug; 86(2):253-8. PubMed ID: 807663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deficient serum bactericidal activity against Escherichia coli in patients with cirrhosis of the liver.
    Fierer J; Finley F
    J Clin Invest; 1979 May; 63(5):912-921. PubMed ID: 376551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deficiency of serum bactericidal activity against Salmonella typhimurium in sickle cell anaemia.
    Hand WL; King NL
    Clin Exp Immunol; 1977 Nov; 30(2):262-70. PubMed ID: 342154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bactericidal activity of normal human serum to gram-negative rods with sialic acid containing lipopolysaccharide].
    Bugla G; Doroszkiewicz W; Gamian A; Korzeniowska-Kowal A
    Med Dosw Mikrobiol; 2004; 56(3):255-61. PubMed ID: 15773502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on rabbit hyperimmune, patient and blood donor serum with regard to bactericidal activity and serum antibodies against anaerobic curved rods from patients with bacterial vaginosis.
    Moi H; Danielsson D
    Scand J Urol Nephrol Suppl; 1984; 86():87-91. PubMed ID: 6399411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired bactericidal activity of cord sera against Salmonella strains.
    Jankowski S; Konrad A; Grzybek-Hryncewicz K
    Arch Immunol Ther Exp (Warsz); 1983; 31(2):249-53. PubMed ID: 6360075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The analysis of the complement activation product SC5 b-9 is applicable in neonates in spite of their profound C9 deficiency.
    Høgåsen AK; Overlie I; Hansen TW; Abrahamsen TG; Finne PH; Høgåsen K
    J Perinat Med; 2000; 28(1):39-48. PubMed ID: 10765513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human seminal plasma inhibition of complement.
    Petersen BH; Lammel CJ; Stites DP; Brooks GF
    J Lab Clin Med; 1980 Oct; 96(4):582-91. PubMed ID: 6775032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum bactericidal and opsonic activities in patients with non-alcoholic cirrhosis.
    Akalin HE; Laleli Y; Telatar H
    Q J Med; 1985 Aug; 56(220):431-7. PubMed ID: 3901076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune bactericidal reactions by guinea-pig gamma1 and gamma2 antibodies.
    Siroták L; Inoue K; Okada M; Amano T
    Immunology; 1976 Mar; 30(3):435-41. PubMed ID: 815178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Supplemental complement component C9 enhances the capacity of neonatal serum to kill multiple isolates of pathogenic Escherichia coli.
    Lassiter HA; Wilson JL; Feldhoff RC; Hoffpauir JM; Klueber KM
    Pediatr Res; 1994 Apr; 35(4 Pt 1):389-96. PubMed ID: 8047374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A peptide derived from human bactericidal/permeability-increasing protein (BPI) exerts bactericidal activity against Gram-negative bacterial isolates obtained from clinical cases of bovine mastitis.
    Chockalingam A; McKinney CE; Rinaldi M; Zarlenga DS; Bannerman DD
    Vet Microbiol; 2007 Nov; 125(1-2):80-90. PubMed ID: 17560054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further studies on C9 deficiency.
    Kitamura H; Nagaki K; Inai S
    J Clin Lab Immunol; 1981 Jul; 6(1):7-11. PubMed ID: 7265179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement consumption by Photobacterium damselae subsp. piscicida in seabream, red porgy and seabass normal and immune serum. Effect of the capsule on the bactericidal effect.
    Acosta F; Ellis AE; Vivas J; Padilla D; Acosta B; Déniz S; Bravo J; Real F
    Fish Shellfish Immunol; 2006 May; 20(5):709-17. PubMed ID: 16263309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of C9 in complement-mediated killing of Neisseria.
    Harriman GR; Esser AF; Podack ER; Wunderlich AC; Braude AI; Lint TF; Curd JG
    J Immunol; 1981 Dec; 127(6):2386-90. PubMed ID: 6795273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.